M. Materazzi

The good use of plasma. A critical analysis of five international guidelines.

A. Iorio, M. Basileo, E. Marchesini, 2008, Blood transfusion = Trasfusione del sangue.

T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature.

S. Pileri, F. Gherlinzoni, B. Falini, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Hereditary Hemochromatosis Type 3, Analysis of M172k Mutational Sequence in A Single Male Patient

E. Illiano, M. Materazzi, S. Brancorsini, 2020, Biomedical Journal of Scientific & Technical Research.

Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase.

A. Iorio, M. Basileo, E. Marchesini, 2008, Blood transfusion = Trasfusione del sangue.

In Vivo and in Vitro Evidence of an Adenosine-Mediated Mechanism of Calcium Entry Blocker Activities

P. Capecchi, M. Materazzi, F. Laghi Pasini, 1989, Angiology.

Effects of a calcium-antagonist (flunarizine) on cancer cell movement and phagocytosis.

M. Materazzi, M. L. Sezzi, L. Bellelli, 1985, Anticancer research.

Effects of a calcium-antagonist (flunarizine) on the in vitro growth of B16 mouse melanoma cells.

G. Zupi, M. Materazzi, M. L. Sezzi, 1984, Anticancer research.

In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine.

M. Materazzi, A. Bellelli, M. Mattioni, 1987, Oncology.

Pharmacological Basis and Therapeutic Efficacy of Flunarizine in Peripheral Artery Disease

M. Materazzi, F. Pasini, S. Pecchi, 1988, Annals of the New York Academy of Sciences.

Protective Effects of Buflomedil against Exercise-Induced Reductions in Regional Erythrocyte Deformability of Patients with Peripheral Arterial Disease

M. Materazzi, S. Forconi, M. Guerrini, 1982, The Journal of international medical research.